Novel Insights from Blood Speckle Imaging for the Assessment of Left Ventricular Flow Dynamics in Adult Patients: A Three‐Patient Proof‐of‐Concept Case Series in the Context of Current Evidence

Transthoracic echocardiography is the cornerstone of cardiac imaging, yet conventional volumetric and Doppler indices may fail to detect clinically meaningful changes in ventricular performance. Patients often improve symptomatically and biochemically after device-based or medical therapies without parallel changes in standard echocardiographic measures, reflecting that the left ventricle functions not only as a pressure-volume pump but as a complex fluid-dynamic system in which myocardial mechanics and intracavitary blood flow are tightly coupled. Blood speckle imaging (BSI) tracks red blood cell speckle patterns, enabling angle-independent, contrast-free, real-time visualization and qualitative assessment of intraventricular vortex organization. We present a three-patient proof-of-concept case series including non-ischemic dilated cardiomyopathy treated with cardiac contractility modulation, ischemic cardiomyopathy managed by conduction-system pacing (CSP), and heart failure with preserved ejection fraction treated with medical optimization. BSI was performed before and after therapy and interpreted alongside a review of the intracardiac flow-dynamics literature. In all patients, symptoms and N-terminal pro-B-type natriuretic peptide levels improved despite minimal changes in left ventricular volumes and conventional systolic indices, whereas BSI revealed reorganization of intraventricular flow, characterized by fewer competing vortices, reduced late-diastolic persistence, and more physiological vortex positioning. These observations support the hypothesis that flow reorganization may represent an early marker of ventricular recovery preceding detectable structural remodeling. To our knowledge, this is among the first adult reports of therapy-associated left ventricular flow reorganization assessed by BSI across distinct heart failure phenotypes. These findings are hypothesis-generating and require prospective validation against quantitative four-dimensional flow cardiovascular magnetic resonance.